文献速递脊柱关节炎

计量学在轴性脊柱关节炎中的作用:是否提供独特信息以评估患者和预测结局?

Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-02-06

基于英国风湿病学会生物制剂注册的前瞻性队列研究,纳入1960例符合ASAS标准的轴性脊柱关节炎患者,分析脊柱活动度(BASMI)的相关因素及其对anti-TNF治疗反应的预测价值。结果显示BASMI与其他常规因素中度相关,且对部分(非全部)常用疗效指标有独立预测作用。

要点

  • BASMI与功能差、影像学AS、病程长、CRP高、年龄大、男性、未就业和低教育水平独立相关。
  • 51%患者实测BASMI与估计值相差在1以内。
  • 较高BASMI独立预测未达到ASAS20、ASAS40和生活质量反应,但与ASDAS反应无关。

核心结论

  • BASMI可被其他常规测量因素中度估计,且对部分常用疗效指标有独立预测作用,但对ASDAS反应无预测价值。

研究设计与样本

  • 前瞻性英国队列研究,纳入1960例符合ASAS标准的轴性SpA患者,中位年龄48岁,70%男性,中位BASMI 3.6。

主要发现

  • 与差脊柱活动度独立相关的因素包括功能差、符合AS放射学标准、症状持续时间长、CRP高、年龄大、男性、未就业和低教育水平。
  • 51%参与者实测BASMI与估计值相差在1以内。
  • 较高BASMI独立预测未达到ASAS20(OR 0.80,IQR 0.66-0.98)、ASAS40(OR 0.69,IQR 0.50-0.95)和生活质量反应(β=0.64,IQR 0.26-1.02),但与ASDAS反应标准无关。

关键数值与推荐

  • ASAS20反应:OR 0.80(IQR 0.66, 0.98);ASAS40反应:OR 0.69(IQR 0.50, 0.95);生活质量:β=0.64(IQR 0.26, 1.02)。

临床怎么用

  • BASMI可作为轴性SpA患者脊柱活动度的评估工具,并对anti-TNF治疗的部分反应指标有预测价值。

局限性

  • BASMI在疾病监测和临床决策中的作用尚需共识,尤其在面对面咨询可能减少的背景下。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine among patients with axial spondyloarthritis (SpA) the factors associated with decreased spinal mobility and to determine whether poor mobility is a predictor of response to anti-tumor necrosis factor (anti-TNF) therapy. METHODS: This was a prospective UK cohort study of persons meeting Assessment of Spondylarthritis international Society (ASAS) criteria for axial SpA. At recruitment, clinical and patient-reported factors independently associated with spinal mobility (measured by the Bath Ankylosing Spondylitis Metrology Index [BASMI]) were determined. Among those commencing anti-TNF therapy, factors that were independent predictors of response were determined using ASAS criteria, quality of life, and Ankylosing Spondylitis Disease Activity Score (ASDAS) response criteria. RESULTS: A total of 1,960 participants were eligible; 70% were male, the median age was 48 years (interquartile range [IQR] 37, 59), and the median BASMI score 3.6 (IQR 2.2, 5.3). Factors independently associated with poor spinal mobility were poorer function, meeting radiographic criteria for AS, longer symptom duration, higher levels of inflammation (measured by C-reactive protein level), older age, male sex, not being currently employed, and lower levels of education. For 51% of participants, the measured BASMI score was within 1 of that estimated. Poorer mobility (higher BASMI score) was an independent predictor of not meeting response criteria for ASAS 20% improvement (odds ratio [OR] per increasing score 0.80 [IQR 0.66, 0.98]), ASAS 40% improvement (OR 0.69 [IQR 0.50, 0.95]), and quality of life (measured by the Ankylosing Spondylitis Quality of Life Questionnaire) (β = 0.64 [IQR 0.26, 1.02]), but was not related to meeting ASDAS response criteria. CONCLUSION: The BASMI score was estimated moderately well by other routinely measured factors in patients with axial SpA and was an independent predictor of response to biologic therapy for some, but not all, commonly used measures. Consensus around its role in disease monitoring and clinical decisions, particularly in the likely context of face-to-face consultations becoming less frequent, remains to be established.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Biallas RL, Dean LE, Davidson L, et al. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2022. PMID: 33140891. doi:10.1002/acr.24500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。